论文部分内容阅读
Oral dichloroacetate sodium(DCA)has been investigated as a novel metabolic therapy for various cancers since 2007,based on data from Bonnet et al that DCA can trigger apoptosis of human lung,breast and brain cancer cells.Response to therapy in human studi